These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3113406)

  • 1. Massive hollow fiber clotting: a distinct problem in treatment of cryoglobulinemia by membrane plasmapheresis.
    Lai KN; Cheng SC; Vallance-Owen J
    Artif Organs; 1987 Jun; 11(3):259-64. PubMed ID: 3113406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic apheresis: when things go wrong.
    Torloni AS; Lumadue J; Zubair A
    J Clin Apher; 2012; 27(3):168-71. PubMed ID: 22504899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of emergency apheresis in the management of plasma cell disorders.
    Kalayoglu-Besisik S
    Transfus Apher Sci; 2018 Feb; 57(1):35-39. PubMed ID: 29477943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis and paraproteinemia: cryoprotein-induced diseases, monoclonal gammopathy, Waldenström's macroglobulinemia, hyperviscosity syndrome, multiple myeloma, light chain disease, and amyloidosis.
    Siami GA; Siami FS
    Ther Apher; 1999 Feb; 3(1):8-19. PubMed ID: 10079800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmapheresis and cold sensitivity of immunoglobulin molecules. I. A study of hyperviscosity, cryoglobulinemia, euglobulinemia and macroglobulinemia vera.
    Waldenström JG; Raiend U
    Acta Med Scand; 1984; 216(5):449-66. PubMed ID: 6441457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of fractionation characteristics in cascade filtration.
    Busnach G; Mandelli E; Brando B; Brunati C
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():155-9. PubMed ID: 8013978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of plasmapheresis on the PF-0.5 blood separator in patients with paraproteinemic hemoblastoses].
    Abdullaev OM; Postnikov AA; Prigozhina TA; Likhovetskaia ZM; Mokeeva RA
    Ter Arkh; 1987; 59(10):77-81. PubMed ID: 2448887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Waldenström's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia.
    Stone MJ
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):97-9. PubMed ID: 19362986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDL-cholesterol sparing and APO-B removal in recycled cascade plasmafiltration.
    Busnach G; Brando B; Dal Col A; Perrino ML; Zoppi F; Minetti L
    ASAIO Trans; 1986; 32(1):168-70. PubMed ID: 3096353
    [No Abstract]   [Full Text] [Related]  

  • 10. [Alleviation of ocular complications of the hyperviscosity syndrome in Waldenström's macroglobulinemia using plasma exchange].
    Malecaze F; Mathis A; Gonzales C; Lloveras JJ; Goudable C; Arlet P; Bec P
    J Fr Ophtalmol; 1986; 9(5):367-71. PubMed ID: 3100607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperviscosity syndrome: efficacy and comparison of plasma exchange by plasma separation and cascade filtration in patients with immunocytoma of Waldenström's type.
    Höffkes HG; Heemann UW; Teschendorf C; Uppenkamp M; Philipp T
    Clin Nephrol; 1995 May; 43(5):335-8. PubMed ID: 7634550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based focused review of management of hyperviscosity syndrome.
    Stone MJ; Bogen SA
    Blood; 2012 Mar; 119(10):2205-8. PubMed ID: 22147890
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and clinical evaluation of a new cellulose diacetate secondary filter for cascade filtration.
    Valbonesi M; Tarantino M; Montani F; Florio G; Romorini A
    Int J Artif Organs; 1985 Mar; 8(2):105-8. PubMed ID: 3921467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma exchange in the long-term management of Waldenström's macroglobulinemia.
    Buskard NA; Galton DA; Goldman JM; Kohner EM; Grindle CF; Newman DL; Twinn KW; Lowenthal RM
    Can Med Assoc J; 1977 Jul; 117(2):135-7. PubMed ID: 406031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of plasmapheresis in Waldenström's macroglobulinemia.
    Stone MJ; Bogen SA
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):238-40. PubMed ID: 23522642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing Plasmapheresis Efficacy in Waldenstrom Macroglobulinemia: Overcoming Circuit Clotting Challenges.
    Khan U; Sharma S; Prasad P; Agarwal A; Jain A; Jain A; Verma H
    Semin Dial; 2024; 37(3):282-283. PubMed ID: 38506146
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of intensive plasmapheresis on the "syndrome of increased viscosity" and blood coagulation system in Waldenstrom's macroglobulinemia].
    Mokeeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1969 Mar; 14(3):8-16. PubMed ID: 4981700
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperviscosity syndrome in Waldenström's macroglobulinemia.
    Krol TC; Wood WS
    Am Fam Physician; 1981 Aug; 24(2):187-9. PubMed ID: 6789661
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful use of cryocrit for monitoring response to therapeutic plasma exchange in type 1 cryoglobulinemia.
    Olson N; Yerrabothala S; Dunbar N
    J Clin Apher; 2016 Aug; 31(4):403-4. PubMed ID: 26194475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and rheological studies in a patient with hyperviscosity syndrome due to Waldenström's macroglobulinemia.
    Somer T; Ditzel J
    Bibl Haematol; 1981; (47):242-6. PubMed ID: 6802129
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.